Abstract

Background. This paper evaluates the status of reporting information related to the usage and ethical issues of artificial intelligence (AI) procedures in clinical trial (CT) papers focussed on radiology issues as well as other (non-trial) original radiology articles (OA). Material and Methods. The evaluation was performed by three independent observers who were, respectively physicist, physician and computer scientist. The analysis was performed for two groups of publications, i.e., for CT and OA. Each group included 30 papers published from 2018 to 2020, published before guidelines proposed by Liu et al. (Nat Med. 2020; 26:1364-1374). The set of items used to catalogue and to verify the ethical status of the AI reporting was developed using the above-mentioned guidelines. Results. Most of the reviewed studies, clearly stated their use of AI methods and more importantly, almost all tried to address relevant clinical questions. Although in most of the studies, patient inclusion and exclusion criteria were presented, the widespread lack of rigorous descriptions of the study design apart from a detailed explanation of the AI approach itself is noticeable. Few of the chosen studies provided information about anonymization of data and the process of secure data sharing. Only a few studies explore the patterns of incorrect predictions by the proposed AI tools and their possible reasons. Conclusion. Results of review support idea of implementation of uniform guidelines for designing and reporting studies with use of AI tools. Such guidelines help to design robust, transparent and reproducible tools for use in real life.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.